News archive

Information from Lifecare – August 2022

August 8, 2022
Independent experts from the European Commission’s Innovation Radar have reviewed Lifecares technology in the EU funded project FORGETDIABETES. The review concludes that Lifecare’s innovations are “Market Ready” and considered among the top 14% of innovations in scientific projects receiving financial grants from the European Commission.   Lifecare is part of the EU funded research project […]
Read more

Information from Lifecare — July 2022

July 4, 2022
Lifecare achieved the two major milestones for 1H2022 in June and continue to strengthen the organization. It was a very important milestone for Lifecare to conclude successful, high-quality and reproduceable in-vitro test results with the fabricated Sencell sensor prototypes for the clinical trials on 2 June 2022: https://newsweb.oslobors.no/message/563975 Following this achievement, Lifecare continued the prototype […]
Read more

Information from Lifecare – June

June 9, 2022
Lifecare has recently concluded successful in-vitro test results of the miniaturized Sencell sensor. This represents a milestone achievement of the Sencell development, and the impact of the in-vitro tests reaches even further. Learn more about the importance of these test results, as well as further increase of staff in the Lifecare Group, a nationwide press […]
Read more

Lifecare open position

May 4, 2022
For our development site in Reutlingen, Germany, we have an open position as: Technical research scientist / electrical engineer for Biomedical MEMS   Main responsibilities will be: Taking responsibility for the measurement techniques, mainly, programming and interfacing the readout devices at our facilities in Germany (Reutlingen). Investigating low noise instrumentation/devices, implementing, and testing them on […]
Read more

Information from Lifecare – April 2022

April 4, 2022
Demonstration of nano-scale dispensing of biochemical solutions on the Sencell chip and an article in the Norwegian Technical Weekly. Upcoming events and an operational update.  Read more below:   Nanofluidics and assembly The Sencell Glucose sensor is based on a pre-produced silicon chip where Lifecare in the first step applies nano-scale pressure sensors and microelectronics. […]
Read more

Article Teknisk Ukeblad March 2022

March 22, 2022
CEO Joacim Holter was interviewed by the Norwegian Magazine Teknisk ukeblad in March 2022. Read more here (Norwegian only): Norsk teknologi kan gjøre livet lettere for diabetikere – Tu.no
Read more

Spotting Sencell video

March 21, 2022
March 10, 2022 we visited the bioinstrumention company GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH in Radeberg, Germany. GeSiM develops micro and nanoscale liquid handling instruments. In the video you can see a demonstration of how the chambers in the Sencell sensor can be filled with approximately 300 nanoliter of liquid, before glue is applied on the housing […]
Read more

Information from Lifecare – February 2022

February 28, 2022
Following the restructuring of Lifecare including the acquisition of the two operational German subsidiaries Lifecare NanoBioSensors and Lifecare Laboratories, the Lifecare Board of Directors, management, and key personnel have conducted an inspiring and productive workshop in Mainz, Germany. Due to a current high demand for Covid PCR testing, Lifecare Laboratories experiences an extraordinarily high activity […]
Read more

Lifecare open position

February 4, 2022
To oversee product development and initial preparations for production, in close collaboration with our R&D departments, Lifecare is looking for a Product Development Manager Main responsibilities Implementation and follow-up of Quality Management System Coordinate product development and production preparations in collaboration with the CSO. Support the coordination of regulatory studies in different locations.   Read […]
Read more

Information from Lifecare – January 2022

January 31, 2022
The overall aim for Lifecare in 2022 is to initiate clinical activities in line with our development milestones. The planned activities will bring our unique Sencell osmotic sensing technology a significant step closer to regulatory approval as a medical device for diabetes care. Preparations to ensure a regulatory approved platform have been initiated and we […]
Read more